Fluid Status and Body Composition Analysis by Bioelectrical Impedance in Patients After Cardiac Surgery (FLUBIACS)
FLUBIACS
1 other identifier
observational
150
1 country
1
Brief Summary
Evaluation of fluid status in cardiac surgery patients using bioelectrical impedance and its impact on postoperative morbidity and mortality
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedFirst Posted
Study publicly available on registry
July 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedJuly 12, 2024
July 1, 2024
1 year
June 26, 2024
July 4, 2024
Conditions
Outcome Measures
Primary Outcomes (7)
Fluid distribution during the early postoperative period (≤ 5 days)
Phase angle (in degrees)
Perioperative period (preoperatively, on the first, third, and fifth postoperative day)
Fluid distribution during the early postoperative period (≤ 5 days)
Impedance ratio
Perioperative period (preoperatively, on the first, third, and fifth postoperative day)
Fluid distribution during the early postoperative period (≤ 5 days)
Total body water (TBW), extracellular water (ECW), intracellular water (ICW) (in litres)
Perioperative period (preoperatively, on the first, third, and fifth postoperative day)
Fluid distribution during the early postoperative period (≤ 5 days)
Oedema index (ECW/TBW ratio)
Perioperative period (preoperatively, on the first, third, and fifth postoperative day)
Fluid distribution during the early postoperative period (≤ 5 days)
Body cell mass (in kilograms)
Perioperative period (preoperatively, on the first, third, and fifth postoperative day)
Fluid distribution during the early postoperative period (≤ 5 days)
Skeletal muscle mass (in kilograms)
Perioperative period (preoperatively, on the first, third, and fifth postoperative day)
Fluid distribution during the early postoperative period (≤ 5 days)
Bioelectrical impedance vector analysis
Perioperative period (preoperatively, on the first, third, and fifth postoperative day)
Secondary Outcomes (6)
Impact of fluid distribution/fluid overload on duration of postoperative mechanical ventilation
Duration of stay in ICU (estimated to up to 5 days)
Impact of fluid distribution/fluid overload on postoperative complications (myocardial infarction, cardiogenic shock, vasoplegia, atrial fibrillation, heart failure, bleeding, infections, delirium)
Up to 1 year after the operation
Impact of fluid distribution/fluid overload on length of stay in the intensive care unit
Duration of stay in ICU (estimated to up to 5 days)
Impact of fluid distribution/fluid overload on length of hospitalisation
Duration of hospital stay (up to 1 month)
Impact of fluid distribution/fluid overload on 30-day postoperative mortality
On day 30
- +1 more secondary outcomes
Study Arms (2)
On-pump cardiac surgery
Patients undergoing cardiac surgery with cardiopulmonary bypass
Off-pump cardiac surgery
Patients undergoing cardiac surgery without cardiopulmonary bypass
Interventions
Fluid distribution measured by bioelectrical impedance Bodystat Multiscan 5000 Bodystat Ltd, Isle of Man, British Isles
Eligibility Criteria
Adults (18 years or over) undergoing elective cardovascular surgery (on-pump or off-pump)
You may qualify if:
- Elective cardiovascular surgery (on-pump or off-pump)
- Age ≥ 18 years
- ASA 3 or 4
- Provided verbal and written informed consent
You may not qualify if:
- Refusal to participate in the research
- \< 18 years
- Renal failure requiring replacement treatment with hemodialysis
- Amputation of a limb
- Pregnancy
- Emergency Procedures
- Reoperation
- Pacemaker/implantable cardioverter-defibrillator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anaesthesiology and Surgical Intensive Care, University Medical Centre Ljubljana
Ljubljana, Slovenia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gordana Taleska Štupica, MD, PhD, DESA, EDIC
Department of Anaesthesiology and Surgical Intensive Care, University Medical Centre Ljubljana
- PRINCIPAL INVESTIGATOR
Laura Kekec, MD
Department of Anaesthesiology and Surgical Intensive Care, University Medical Centre Ljubljana
- STUDY DIRECTOR
Matej Jenko, MD
Department of Anaesthesiology and Surgical Intensive Care, University Medical Centre Ljubljana
- STUDY DIRECTOR
Maja Šoštarič, MD, PhD
Department of Anaesthesiology and Surgical Intensive Care, University Medical Centre Ljubljana
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 26, 2024
First Posted
July 12, 2024
Study Start
July 1, 2024
Primary Completion
July 1, 2025
Study Completion (Estimated)
July 1, 2026
Last Updated
July 12, 2024
Record last verified: 2024-07